Stable cytochrome P450 24 (CYP24) expressing cell line and...

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S025000, C435S069100, C435S189000, C435S320100, C536S023200

Reexamination Certificate

active

10513302

ABSTRACT:
The invention relates to a stable recombinant host cell comprising a CYP24 nucleic acid. The host cell is preferably a mammalian cell or an insect cell. The cell is useful for identifying modulators of CYP24 that can be used in the treatment of CYP24 expression-related medical conditions.

REFERENCES:
patent: 4373071 (1983-02-01), Itakura
patent: 4401796 (1983-08-01), Itakura
patent: 4458066 (1984-07-01), Caruthers et al.
patent: 4598049 (1986-07-01), Zelinka et al.
patent: 2005/0042730 (2005-02-01), Kato et al.
patent: WO 97/49815 (1997-12-01), None
patent: WO 01/44443 (2001-06-01), None
Sakaki et al. J. Biosci. Bioengin 2000, vol. 90, pp. 583-590.
Chen et al . PNAS 1993, 90, 4543-4547.
Beal et al., “Second Structural Motif for Recognition of DNA by Oligonucleotide-Directed Triple-Helix Formation”, Science, Mar. 15, 1991, vol. 251(4999), pp. 1360-1363.
Bligh et al., Can. J. Biochem.37:911-917. 1959.
Brutlag et al., “Improved sensitivity of biological sequence database searches”, Comput Appl Biosci., vol. 6(3), pp. 237-245, USA.
Chen et al., “Isolation and expression of human 1,-25-dihydroxyvitamin D3 24-hydroxylase cDNA” Proc. Natl. Acad. Sci. USA, May 15, 1993, vol. 90(10), pp. 4543-4547, U.S.A.
Cooney et al., “Site-Specific Oligonucleotide Binding Represses Transcription of the Human c-mycGene in Vitro”, Science, Jul. 22, 1988, vol. 241(4864), pp. 456-459.
Dilworth et al., “Different Mechanisms of Hydroxylation Site Selection by Liver and Kidney Cytochrome P450 Species (CYP27 adn CYP24) Involved in Vitamin D Metabolism”, J. Biol. Chem., Jul. 14, 1995, vol. 270(28), pp. 16766-16774, U.S.A.
Itoh et al., “Molecular cloning of 25-hydroxyvitamin D-3 24-hydroxylase (Cyp-24) from mouse kidney: its inducibility by vitamin D-3”, Biochim. Biophys. Acta., Oct. 17, 1995, vol. 1264(1), pp. 26-28.
Itoh et al., “Simultaneous expression of ferredoxin, ferredoxin reductase and P450 in COS7 cells”, Biochim. Biophys. Acta., Jan. 16, 1997, vol. 1318(1-2), pp. 284-290.
Jones et al., “Expression and Activity of Vitamin D-Metabolizing Cytochrome P450s (CYP1α and CYP24) in Human Nonsmall Cell Lung Carcinomas”, Endocrinology, Jul. 1999, vol. 140(7), pp. 3303-3310.
Kaufman et al., Poster Presentation: 23rd Annual Meeting of the American Society for Bone and Mineral Research, J. Bone Miner. Res., Oct. 12-16, 2001, vol. 16(Supp. 1), Abstract SA529, U.S.A.
Lee et al., “Complexes formed by (pyrimidine)n(purine)nDNAs on lowering the pH are three-sided”, Nucl. Acids Res., Apr. 2, 1979, vol. 6(9), pp. 3073-3091.
Masuda et al., “Vitamin D Analogs- Drug Design Based on Proteins Involved in Vitamin D Signal Transduction”, Curr. Drug Targets Immune Endocr Metabol Disord, Mar. 2003, vol. 3(1), pp. 43-66.
Peehl et al., “Preclinical Activity of Ketoconazole in Combination With Calcitriol or the Vitamin D Analogue Eb 1089 in Prostate Cancer Cells”, J Urol, Oct. 2002, vol. 168(4, pt. 1of2), pp. 1583-1588.
Okano, “Oligodeoxynucleotides as Antisense Inhibitors of Gene Expression”, J. Neurochem, 1991, vol. 56(560).
Ray et al., “Metabolism of 2 3H-1alpha, 2-dihydroxyvitamin D3 in the cultures human keratinocytes” J. Cell. Biochem., 1995, vol. 59(1), pp. 117-122.
Schuster et al., “Selective inhibition if vitamin D hydroxylases in human keratinocytes”, Steroids, May 1, 2001, vol. 66(5), pp. 409-422.
Sakaki et al., “Dual metabolic pathway of 25-hydroxyvitamin D3catalyzed by human CYP24”, Eur. J. Biochem., Oct. 2000, vol. 267(20), pp. 6158-6165.
White et al., “Identification of the Retinoic Acid-inducible All-trans-retinoic Acid 4-Hydroxylase”, J. Biol. Chem., Nov. 22, 1996, vol. 271(47), pp. 29922-29927, U.S.A.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Stable cytochrome P450 24 (CYP24) expressing cell line and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stable cytochrome P450 24 (CYP24) expressing cell line and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable cytochrome P450 24 (CYP24) expressing cell line and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3866053

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.